Arts

Books

Fashion & Beauty

Performing Arts

Food

Visual Arts

Design

Business

Entrepreneurship

Investing

Marketing

Careers

Management

Non-Profit

Comedy

Stand-Up

Comedy Interviews

Improv

Education

Self-Improvement

How To

Courses

Language Learning

Fiction

Comedy Fiction

Drama

Science Fiction

Government

Health & Fitness

Medicine

Alternative Health

Nutrition

Mental Health

Fitness

Sexuality

History

Kids & Family

Parenting

Stories for Kids

Education for Kids

Pets & Animals

Leisure

Video Games

Games

Automotive

Animation & Manga

Hobbies

Aviation

Home & Garden

Crafts

Music

Music Commentary

Music Interviews

Music History

News

Sports News

Entertainment News

News Commentary

Politics

Daily News

Business News

Tech News

Religion & Spirituality

Christianity

Spirituality

Religion

Judaism

Islam

Buddhism

Hinduism

Science

Social Sciences

Life Sciences

Natural Sciences

Nature

Chemistry

Mathematics

Earth Sciences

Physics

Astronomy

Society & Culture

Documentary

Relationships

Philosophy

Personal Journals

Places & Travel

Sports

Golf

Soccer

Wrestling

Basketball

Football

Fantasy Sports

Baseball

Wilderness

Running

Hockey

Rugby

Cricket

Volleyball

Tennis

Swimming

Technology

True Crime

TV & Film

Film Interviews

TV Reviews

After Shows

Film Reviews

Film History

Pharmacy Life Radio

A weekly talk show about lifestyle science, plant-based nutrition, and athletic performance.

Thought For Food Podcast

Featuring one-on-one discussions with leading oncology investigators, this series assists clinicians with the formulation of up-to-date clinical management strategies so that they can provide optimal care for patients with melanoma and nonmelanoma skin cancer.

Dermatologic Oncology Update

Dies ist der Podcast der Praxis für Kinderhomöopathie von Vera Kaesemann. Hier erfährst du alles rund um die Kindergesundheit und deren ganzheitliche Behandlung, von Klassischer Homöopathie über Psychosomatik bis hin zu Naturheilkunde und bewährten Hausmitteln. Vera Kaesemann ist seit über 25 Jahren Kinderhomöopathin in eigener Praxis in Hamburg, 2009 erschien ihr erstes Buch, Krankheit als Sprache der Kinderseele (Bertelsmann), zusammen mit Dr. Ruediger Dahlke.

Ganzheitliche Kindergesundheit

A case based discussion podcast for maxillofacial surgery trainees

Maxillofacial Surgery

In the heart of a bustling research lab at Oxford University, Dr. Sarah Johnson peered intently into her microscope. For years, she and her team had been working tirelessly on a project that could change the lives of millions. Their goal? To create a vaccine that could finally put an end to one of humanity's oldest and deadliest foes: malaria. Sarah's journey had begun years earlier when, as a young medical student, she had volunteered in a rural clinic in Burkina Faso. There, she had witnessed firsthand the devastating impact of malaria, particularly on children. The image of a mother cradling her feverish child, helpless against the parasites ravaging the little one's body, had stayed with her ever since. "We're close," Sarah muttered to herself, adjusting the focus on her microscope. "I can feel it." And indeed, they were. After years of painstaking research, countless failures, and glimmers of hope, Sarah and her team had developed a vaccine they called R21/Matrix-M. It was a mouthful of a name, but it held the promise of saving countless lives. Meanwhile, in a small village in Ghana, Kwame sat outside his home, swatting at mosquitoes in the evening air. His young daughter, Ama, lay inside, her small body wracked with fever. Malaria had struck again, as it did every year when the rains came. Kwame had lost his eldest son to the disease three years ago. Now, as he listened to Ama's labored breathing, he prayed for a miracle. Little did he know that halfway across the world, that miracle was taking shape in the form of a tiny vial of vaccine. Back in Oxford, Sarah's team received the news they had been waiting for. The results from their latest clinical trial were in, and they were nothing short of remarkable. The R21/Matrix-M vaccine had shown an efficacy rate of up to 77% in young children who received a booster dose. "This is it!" Sarah exclaimed, her eyes shining with excitement as she shared the news with her team. "We've done it!" But what exactly had they done? How did this tiny vial of liquid manage to outsmart a parasite that had been outwitting humans for millennia? The secret lay in the vaccine's clever design. It targeted a specific protein found on the surface of the malaria parasite called the circumsporozoite protein, or CSP for short. Think of CSP as the parasite's coat – by teaching the body's immune system to recognize and attack this coat, the vaccine effectively stopped the parasite in its tracks before it could cause harm. But the R21/Matrix-M vaccine had another trick up its sleeve. It included a special ingredient called an adjuvant – Matrix-M. This adjuvant worked like a megaphone for the immune system, amplifying the body's response to the vaccine and making it more effective. As news of the vaccine's success spread, it reached the ears of world leaders and health organizations. In boardrooms and government offices, plans were set in motion to bring this life-saving vaccine to those who needed it most. Ghana, Nigeria, and Burkina Faso were chosen as the first countries to receive the vaccine. For people like Kwame and his daughter Ama, this news brought a glimmer of hope in their ongoing battle against malaria. The logistics of distributing the vaccine were daunting. It required a coordinated effort between local healthcare providers, governments, and international health organizations. But the potential impact was too significant to ignore. Dr. Amina Diallo, a public health official in Burkina Faso, stood before a group of local healthcare workers, explaining the importance of the new vaccine. "This is not just another medicine," she said, her voice filled with passion. "This is our chance to rewrite the story of malaria in our country. Each dose we administer is a step towards a healthier future for our children." The rollout began slowly but steadily. In clinics and hospitals across the selected countries, children lined up to receive their shots. Parents, who had lived in fear of malaria for generations, dared to hope that their children might grow up in a world where the disease was no longer a constant threat. For Kwame and Ama, the vaccine came just in time. As Ama recovered from her bout with malaria, Kwame took her to their local clinic to receive the R21/Matrix-M vaccine. "Will this stop her from getting sick again?" Kwame asked the nurse as she prepared the injection. The nurse smiled gently. "It's not a guarantee," she explained, "but it will give her a much better chance of staying healthy. And with each child we vaccinate, we make our whole community stronger against malaria." As the needle entered Ama's arm, Kwame felt a weight lift from his shoulders. For the first time in years, he allowed himself to imagine a future where he didn't have to fear the coming of the rains and the mosquitoes they brought. Back in Oxford, Sarah and her team were far from resting on their laurels. The success of the R21/Matrix-M vaccine had energized them, spurring them on to even greater endeavors. "We've made a huge step forward," Sarah told her team, "but our work is far from over. There are other strains of malaria out there, other stages in the parasite's lifecycle that we can target. We need to keep pushing, keep innovating." And push they did. In labs around the world, inspired by the success of R21/Matrix-M, researchers redoubled their efforts. They explored new approaches, studied different proteins on the parasite's surface, and looked for ways to make vaccines even more effective. The impact of the R21/Matrix-M vaccine was soon felt across the affected regions. Hospital wards that had once been filled to capacity with malaria patients began to see fewer severe cases. Children who might once have missed school due to recurring bouts of the disease were now able to attend classes regularly. Dr. Diallo, reviewing the latest health statistics for her region, could hardly believe her eyes. "The number of malaria cases has dropped by over 50% in just one year," she announced to her team. "This vaccine is not just saving lives; it's transforming our entire healthcare system." Indeed, as the burden of malaria began to lift, hospitals and clinics found they had more resources to dedicate to other pressing health issues. The ripple effects of the vaccine's success were felt throughout society, from increased productivity as fewer work days were lost to illness, to improved educational outcomes as children spent more time in school. But the fight against malaria was far from over. While the R21/Matrix-M vaccine was a powerful tool, it was not a silver bullet. Mosquito control programs, distribution of bed nets, and other preventive measures remained crucial in the ongoing battle against the disease. Moreover, the parasite that caused malaria was notorious for its ability to adapt and evolve. Scientists knew that they needed to stay one step ahead, continuing to refine and improve their vaccines to maintain their effectiveness. Five years after the initial rollout of the R21/Matrix-M vaccine, Kwame stood proudly at Ama's school graduation ceremony. His daughter, now a healthy teenager, had not suffered a single bout of malaria since receiving the vaccine as a child. As he watched Ama accept her diploma, Kwame's mind wandered back to that fearful night when he had sat outside his home, swatting at mosquitoes and praying for a miracle. The miracle had come, not in the form of divine intervention, but through the dedicated work of scientists like Sarah and her team, and the collaborative efforts of countless individuals around the world. In her lab in Oxford, Sarah Johnson looked at a photo on her desk. It showed her standing with a group of smiling children in Burkina Faso, taken during a recent visit to see the impact of the vaccine firsthand. She picked up the photo, a smile playing on her lips. "We've come so far," she murmured, "but there's still so much to do." And with that, she turned back to her microscope, ready to face the next challenge in the ongoing fight against malaria. For Sarah, Kwame, Ama, and millions of others around the world, the R21/Matrix-M vaccine had turned the tide in humanity's ancient battle against the tiny parasite. It was a reminder of what could be achieved when human ingenuity, scientific rigor, and global cooperation came together to tackle even the most formidable of foes. As the sun set over Oxford and rose over Ghana, the world slept a little easier, knowing that each new day brought them closer to a future free from the scourge of malaria. The mosquito's reign of terror was coming to an end, one vaccine dose at a time. The success of the R21/Matrix-M vaccine had far-reaching implications beyond just the realm of public health. It sparked a renewed interest in tropical disease research, attracting funding and talented scientists to a field that had long been underfunded and overlooked. Governments and philanthropic organizations, seeing the tangible results of their investments, increased their support for similar initiatives targeting other neglected diseases. In universities across the globe, a new generation of students, inspired by the breakthrough, chose to pursue careers in infectious disease research and global health. They saw in Sarah's work a model for how science could make a real, measurable difference in the lives of millions. The vaccine's success also had unexpected economic benefits. As malaria rates dropped, tourism to previously high-risk areas began to increase. Local economies that had long suffered under the shadow of the disease started to flourish. Farmers who had once lost precious workdays to illness found themselves more productive, contributing to improved food security in their regions. But perhaps the most profound impact was on the children. In villages and cities across Africa, a generation was growing up without the constant threat of malaria hanging over them. They attended school more regularly, played outside wit

In the heart of a bustling research lab at Oxford University, Dr. Sarah Johnson peered intently into her microscope. For years, she and her team had been working tirelessly on a project that could change the lives of millions. Their goal? To create a vaccine that could finally put an end to one of humanity's oldest and deadliest foes: malaria. Sarah's journey had begun years earlier when, as a young medical student, she had volunteered in a rural clinic in Burkina Faso. There, she had witnessed firsthand the devastating impact of malaria, particularly on children. The image of a mother cradling her feverish child, helpless against the parasites ravaging the little one's body, had stayed with her ever since. "We're close," Sarah muttered to herself, adjusting the focus on her microscope. "I can feel it." And indeed, they were. After years of painstaking research, countless failures, and glimmers of hope, Sarah and her team had developed a vaccine they called R21/Matrix-M. It was a mouthful of a name, but it held the promise of saving countless lives. Meanwhile, in a small village in Ghana, Kwame sat outside his home, swatting at mosquitoes in the evening air. His young daughter, Ama, lay inside, her small body wracked with fever. Malaria had struck again, as it did every year when the rains came. Kwame had lost his eldest son to the disease three years ago. Now, as he listened to Ama's labored breathing, he prayed for a miracle. Little did he know that halfway across the world, that miracle was taking shape in the form of a tiny vial of vaccine. Back in Oxford, Sarah's team received the news they had been waiting for. The results from their latest clinical trial were in, and they were nothing short of remarkable. The R21/Matrix-M vaccine had shown an efficacy rate of up to 77% in young children who received a booster dose. "This is it!" Sarah exclaimed, her eyes shining with excitement as she shared the news with her team. "We've done it!" But what exactly had they done? How did this tiny vial of liquid manage to outsmart a parasite that had been outwitting humans for millennia? The secret lay in the vaccine's clever design. It targeted a specific protein found on the surface of the malaria parasite called the circumsporozoite protein, or CSP for short. Think of CSP as the parasite's coat – by teaching the body's immune system to recognize and attack this coat, the vaccine effectively stopped the parasite in its tracks before it could cause harm. But the R21/Matrix-M vaccine had another trick up its sleeve. It included a special ingredient called an adjuvant – Matrix-M. This adjuvant worked like a megaphone for the immune system, amplifying the body's response to the vaccine and making it more effective. As news of the vaccine's success spread, it reached the ears of world leaders and health organizations. In boardrooms and government offices, plans were set in motion to bring this life-saving vaccine to those who needed it most. Ghana, Nigeria, and Burkina Faso were chosen as the first countries to receive the vaccine. For people like Kwame and his daughter Ama, this news brought a glimmer of hope in their ongoing battle against malaria. The logistics of distributing the vaccine were daunting. It required a coordinated effort between local healthcare providers, governments, and international health organizations. But the potential impact was too significant to ignore. Dr. Amina Diallo, a public health official in Burkina Faso, stood before a group of local healthcare workers, explaining the importance of the new vaccine. "This is not just another medicine," she said, her voice filled with passion. "This is our chance to rewrite the story of malaria in our country. Each dose we administer is a step towards a healthier future for our children." The rollout began slowly but steadily. In clinics and hospitals across the selected countries, children lined up to receive their shots. Parents, who had lived in fear of malaria for generations, dared to hope that their children might grow up in a world where the disease was no longer a constant threat. For Kwame and Ama, the vaccine came just in time. As Ama recovered from her bout with malaria, Kwame took her to their local clinic to receive the R21/Matrix-M vaccine. "Will this stop her from getting sick again?" Kwame asked the nurse as she prepared the injection. The nurse smiled gently. "It's not a guarantee," she explained, "but it will give her a much better chance of staying healthy. And with each child we vaccinate, we make our whole community stronger against malaria." As the needle entered Ama's arm, Kwame felt a weight lift from his shoulders. For the first time in years, he allowed himself to imagine a future where he didn't have to fear the coming of the rains and the mosquitoes they brought. Back in Oxford, Sarah and her team were far from resting on their laurels. The success of the R21/Matrix-M vaccine had energized them, spurring them on to even greater endeavors. "We've made a huge step forward," Sarah told her team, "but our work is far from over. There are other strains of malaria out there, other stages in the parasite's lifecycle that we can target. We need to keep pushing, keep innovating." And push they did. In labs around the world, inspired by the success of R21/Matrix-M, researchers redoubled their efforts. They explored new approaches, studied different proteins on the parasite's surface, and looked for ways to make vaccines even more effective. The impact of the R21/Matrix-M vaccine was soon felt across the affected regions. Hospital wards that had once been filled to capacity with malaria patients began to see fewer severe cases. Children who might once have missed school due to recurring bouts of the disease were now able to attend classes regularly. Dr. Diallo, reviewing the latest health statistics for her region, could hardly believe her eyes. "The number of malaria cases has dropped by over 50% in just one year," she announced to her team. "This vaccine is not just saving lives; it's transforming our entire healthcare system." Indeed, as the burden of malaria began to lift, hospitals and clinics found they had more resources to dedicate to other pressing health issues. The ripple effects of the vaccine's success were felt throughout society, from increased productivity as fewer work days were lost to illness, to improved educational outcomes as children spent more time in school. But the fight against malaria was far from over. While the R21/Matrix-M vaccine was a powerful tool, it was not a silver bullet. Mosquito control programs, distribution of bed nets, and other preventive measures remained crucial in the ongoing battle against the disease. Moreover, the parasite that caused malaria was notorious for its ability to adapt and evolve. Scientists knew that they needed to stay one step ahead, continuing to refine and improve their vaccines to maintain their effectiveness. Five years after the initial rollout of the R21/Matrix-M vaccine, Kwame stood proudly at Ama's school graduation ceremony. His daughter, now a healthy teenager, had not suffered a single bout of malaria since receiving the vaccine as a child. As he watched Ama accept her diploma, Kwame's mind wandered back to that fearful night when he had sat outside his home, swatting at mosquitoes and praying for a miracle. The miracle had come, not in the form of divine intervention, but through the dedicated work of scientists like Sarah and her team, and the collaborative efforts of countless individuals around the world. In her lab in Oxford, Sarah Johnson looked at a photo on her desk. It showed her standing with a group of smiling children in Burkina Faso, taken during a recent visit to see the impact of the vaccine firsthand. She picked up the photo, a smile playing on her lips. "We've come so far," she murmured, "but there's still so much to do." And with that, she turned back to her microscope, ready to face the next challenge in the ongoing fight against malaria. For Sarah, Kwame, Ama, and millions of others around the world, the R21/Matrix-M vaccine had turned the tide in humanity's ancient battle against the tiny parasite. It was a reminder of what could be achieved when human ingenuity, scientific rigor, and global cooperation came together to tackle even the most formidable of foes. As the sun set over Oxford and rose over Ghana, the world slept a little easier, knowing that each new day brought them closer to a future free from the scourge of malaria. The mosquito's reign of terror was coming to an end, one vaccine dose at a time. The success of the R21/Matrix-M vaccine had far-reaching implications beyond just the realm of public health. It sparked a renewed interest in tropical disease research, attracting funding and talented scientists to a field that had long been underfunded and overlooked. Governments and philanthropic organizations, seeing the tangible results of their investments, increased their support for similar initiatives targeting other neglected diseases. In universities across the globe, a new generation of students, inspired by the breakthrough, chose to pursue careers in infectious disease research and global health. They saw in Sarah's work a model for how science could make a real, measurable difference in the lives of millions. The vaccine's success also had unexpected economic benefits. As malaria rates dropped, tourism to previously high-risk areas began to increase. Local economies that had long suffered under the shadow of the disease started to flourish. Farmers who had once lost precious workdays to illness found themselves more productive, contributing to improved food security in their regions. But perhaps the most profound impact was on the children. In villages and cities across Africa, a generation was growing up without the constant threat of malaria hanging over them. They attended school more regularly, played outside wit

In the heart of a bustling research lab at Oxford University, Dr. Sarah Johnson peered intently into her microscope. For years, she and her team had been working tirelessly on a project that could change the lives of millions. Their goal? To create a vaccine that could finally put an end to one of humanity's oldest and deadliest foes: malaria. Sarah's journey had begun years earlier when, as a young medical student, she had volunteered in a rural clinic in Burkina Faso. There, she had witnessed firsthand the devastating impact of malaria, particularly on children. The image of a mother cradling her feverish child, helpless against the parasites ravaging the little one's body, had stayed with her ever since. "We're close," Sarah muttered to herself, adjusting the focus on her microscope. "I can feel it." And indeed, they were. After years of painstaking research, countless failures, and glimmers of hope, Sarah and her team had developed a vaccine they called R21/Matrix-M. It was a mouthful of a name, but it held the promise of saving countless lives. Meanwhile, in a small village in Ghana, Kwame sat outside his home, swatting at mosquitoes in the evening air. His young daughter, Ama, lay inside, her small body wracked with fever. Malaria had struck again, as it did every year when the rains came. Kwame had lost his eldest son to the disease three years ago. Now, as he listened to Ama's labored breathing, he prayed for a miracle. Little did he know that halfway across the world, that miracle was taking shape in the form of a tiny vial of vaccine. Back in Oxford, Sarah's team received the news they had been waiting for. The results from their latest clinical trial were in, and they were nothing short of remarkable. The R21/Matrix-M vaccine had shown an efficacy rate of up to 77% in young children who received a booster dose. "This is it!" Sarah exclaimed, her eyes shining with excitement as she shared the news with her team. "We've done it!" But what exactly had they done? How did this tiny vial of liquid manage to outsmart a parasite that had been outwitting humans for millennia? The secret lay in the vaccine's clever design. It targeted a specific protein found on the surface of the malaria parasite called the circumsporozoite protein, or CSP for short. Think of CSP as the parasite's coat – by teaching the body's immune system to recognize and attack this coat, the vaccine effectively stopped the parasite in its tracks before it could cause harm. But the R21/Matrix-M vaccine had another trick up its sleeve. It included a special ingredient called an adjuvant – Matrix-M. This adjuvant worked like a megaphone for the immune system, amplifying the body's response to the vaccine and making it more effective. As news of the vaccine's success spread, it reached the ears of world leaders and health organizations. In boardrooms and government offices, plans were set in motion to bring this life-saving vaccine to those who needed it most. Ghana, Nigeria, and Burkina Faso were chosen as the first countries to receive the vaccine. For people like Kwame and his daughter Ama, this news brought a glimmer of hope in their ongoing battle against malaria. The logistics of distributing the vaccine were daunting. It required a coordinated effort between local healthcare providers, governments, and international health organizations. But the potential impact was too significant to ignore. Dr. Amina Diallo, a public health official in Burkina Faso, stood before a group of local healthcare workers, explaining the importance of the new vaccine. "This is not just another medicine," she said, her voice filled with passion. "This is our chance to rewrite the story of malaria in our country. Each dose we administer is a step towards a healthier future for our children." The rollout began slowly but steadily. In clinics and hospitals across the selected countries, children lined up to receive their shots. Parents, who had lived in fear of malaria for generations, dared to hope that their children might grow up in a world where the disease was no longer a constant threat. For Kwame and Ama, the vaccine came just in time. As Ama recovered from her bout with malaria, Kwame took her to their local clinic to receive the R21/Matrix-M vaccine. "Will this stop her from getting sick again?" Kwame asked the nurse as she prepared the injection. The nurse smiled gently. "It's not a guarantee," she explained, "but it will give her a much better chance of staying healthy. And with each child we vaccinate, we make our whole community stronger against malaria." As the needle entered Ama's arm, Kwame felt a weight lift from his shoulders. For the first time in years, he allowed himself to imagine a future where he didn't have to fear the coming of the rains and the mosquitoes they brought. Back in Oxford, Sarah and her team were far from resting on their laurels. The success of the R21/Matrix-M vaccine had energized them, spurring them on to even greater endeavors. "We've made a huge step forward," Sarah told her team, "but our work is far from over. There are other strains of malaria out there, other stages in the parasite's lifecycle that we can target. We need to keep pushing, keep innovating." And push they did. In labs around the world, inspired by the success of R21/Matrix-M, researchers redoubled their efforts. They explored new approaches, studied different proteins on the parasite's surface, and looked for ways to make vaccines even more effective. The impact of the R21/Matrix-M vaccine was soon felt across the affected regions. Hospital wards that had once been filled to capacity with malaria patients began to see fewer severe cases. Children who might once have missed school due to recurring bouts of the disease were now able to attend classes regularly. Dr. Diallo, reviewing the latest health statistics for her region, could hardly believe her eyes. "The number of malaria cases has dropped by over 50% in just one year," she announced to her team. "This vaccine is not just saving lives; it's transforming our entire healthcare system." Indeed, as the burden of malaria began to lift, hospitals and clinics found they had more resources to dedicate to other pressing health issues. The ripple effects of the vaccine's success were felt throughout society, from increased productivity as fewer work days were lost to illness, to improved educational outcomes as children spent more time in school. But the fight against malaria was far from over. While the R21/Matrix-M vaccine was a powerful tool, it was not a silver bullet. Mosquito control programs, distribution of bed nets, and other preventive measures remained crucial in the ongoing battle against the disease. Moreover, the parasite that caused malaria was notorious for its ability to adapt and evolve. Scientists knew that they needed to stay one step ahead, continuing to refine and improve their vaccines to maintain their effectiveness. Five years after the initial rollout of the R21/Matrix-M vaccine, Kwame stood proudly at Ama's school graduation ceremony. His daughter, now a healthy teenager, had not suffered a single bout of malaria since receiving the vaccine as a child. As he watched Ama accept her diploma, Kwame's mind wandered back to that fearful night when he had sat outside his home, swatting at mosquitoes and praying for a miracle. The miracle had come, not in the form of divine intervention, but through the dedicated work of scientists like Sarah and her team, and the collaborative efforts of countless individuals around the world. In her lab in Oxford, Sarah Johnson looked at a photo on her desk. It showed her standing with a group of smiling children in Burkina Faso, taken during a recent visit to see the impact of the vaccine firsthand. She picked up the photo, a smile playing on her lips. "We've come so far," she murmured, "but there's still so much to do." And with that, she turned back to her microscope, ready to face the next challenge in the ongoing fight against malaria. For Sarah, Kwame, Ama, and millions of others around the world, the R21/Matrix-M vaccine had turned the tide in humanity's ancient battle against the tiny parasite. It was a reminder of what could be achieved when human ingenuity, scientific rigor, and global cooperation came together to tackle even the most formidable of foes. As the sun set over Oxford and rose over Ghana, the world slept a little easier, knowing that each new day brought them closer to a future free from the scourge of malaria. The mosquito's reign of terror was coming to an end, one vaccine dose at a time. The success of the R21/Matrix-M vaccine had far-reaching implications beyond just the realm of public health. It sparked a renewed interest in tropical disease research, attracting funding and talented scientists to a field that had long been underfunded and overlooked. Governments and philanthropic organizations, seeing the tangible results of their investments, increased their support for similar initiatives targeting other neglected diseases. In universities across the globe, a new generation of students, inspired by the breakthrough, chose to pursue careers in infectious disease research and global health. They saw in Sarah's work a model for how science could make a real, measurable difference in the lives of millions. The vaccine's success also had unexpected economic benefits. As malaria rates dropped, tourism to previously high-risk areas began to increase. Local economies that had long suffered under the shadow of the disease started to flourish. Farmers who had once lost precious workdays to illness found themselves more productive, contributing to improved food security in their regions. But perhaps the most profound impact was on the children. In villages and cities across Africa, a generation was growing up without the constant threat of malaria hanging over them. They attended school more regularly, played outside wit

Malaria Vaccine

Las Vegas HEALS is a coalition of medical and wellness industry professionals, organizations, and institutions devoted to improving the access and delivery of healthcare in Southern Nevada. We are devoted to improving the quality of healthcare and to communicating industry developments to the people of Southern Nevada. Our goal with this podcast is to shine a light on the companies and leaders that serve our valley to help us get to know the ins and outs of our current medical system and what can be done to improve it.

HEALS POD

Dr. Tatyana Reznik, MD is the CEO and founder of AmazVita MD. She is triple board certified in Internal Medicine, Lifestyle Medicine, and Obesity Medicine, plus Menopause Society Certified Practitioner. She specializes in helping women navigate menopause/perimenopause and achieve sustainable weight loss through comprehensive, evidence-based care. Dr. Reznik is a practicing physician and a Certified Life Coach. She interviews many talented women physicians, diving into their journeys to success inside and outside of medicine. Her guests share practical tips from their areas of expertise you can easily apply to your life. Additionally, her solo episodes focus on many effective coaching tools to add more joy to your life. She is here to inspire&nbsp; you, to elevate your voice, and to help you build your happiness toolkit for the journey to Joyful Success!&nbsp; Check out her website at joyfulsuccessliving.com. DISCLAIMER:&nbsp; The Voices of Women Physicians podcast is for entertainment purposes only and does not provide any medical, financial, tax, legal or psychological services or advice. You are responsible for your own wellbeing, decisions and results. Dr. Reznik is a practicing physician but Voices of Women Physicians podcast is not reflective of the opinion of her employer or her guests' employers. You should always contact a professional if you have any specific questions about your unique situation.&nbsp;

Dr. Tatyana Reznik, MD is the CEO and founder of AmazVita MD. She is triple board certified in Internal Medicine, Lifestyle Medicine, and Obesity Medicine, plus Menopause Society Certified Practitioner. She specializes in helping women navigate menopause/perimenopause and achieve sustainable weight loss through comprehensive, evidence-based care. Dr. Reznik is a practicing physician and a Certified Life Coach. She interviews many talented women physicians, diving into their journeys to success inside and outside of medicine. Her guests share practical tips from their areas of expertise you can easily apply to your life. Additionally, her solo episodes focus on many effective coaching tools to add more joy to your life. She is here to inspire  you, to elevate your voice, and to help you build your happiness toolkit for the journey to Joyful Success!  Check out her website at joyfulsuccessliving.com. DISCLAIMER:  The Voices of Women Physicians podcast is for entertainment purposes only and does not provide any medical, financial, tax, legal or psychological services or advice. You are responsible for your own wellbeing, decisions and results. Dr. Reznik is a practicing physician but Voices of Women Physicians podcast is not reflective of the opinion of her employer or her guests' employers. You should always contact a professional if you have any specific questions about your unique situation. 

Voices of Women Physicians

Just Medicine is a podcast on equity in healthcare, hosted by medical students in British Columbia. Each episode, we bring on a guest to chat about a range of social justice topics and how they relate to medicine and health care. The aim of the podcast is to equip medical trainees with the knowledge and skills to provide inclusive care to a growingly diverse population. The podcast is released every second Thursday of the month, starting on January 12, 2023. 

This podcast is not affiliated with UBC Faculty of Medicine and is not meant to provide medical advice.

Just Medicine is a podcast on equity in healthcare, hosted by medical students in British Columbia. Each episode, we bring on a guest to chat about a range of social justice topics and how they relate to medicine and health care. The aim of the podcast is to equip medical trainees with the knowledge and skills to provide inclusive care to a growingly diverse population. The podcast is released every second Thursday of the month, starting on January 12, 2023. This podcast is not affiliated with UBC Faculty of Medicine and is not meant to provide medical advice.

Just Medicine

A Healthcare Transformation Podcast that provides insight and strategies on a wide variety of practice transformation and process improvement topics. Guests include&nbsp; primary care colleagues, practice management staff, and healthcare leaders. &nbsp; We will discuss overcoming barriers to change, process improvement ideas that may spark new ideas for your practice.&nbsp; Hear innovative ideas that practices are implementing to work smarter not harder to meet the demands of the new healthcare environment.&nbsp; &nbsp;

A Healthcare Transformation Podcast that provides insight and strategies on a wide variety of practice transformation and process improvement topics. Guests include  primary care colleagues, practice management staff, and healthcare leaders.   We will discuss overcoming barriers to change, process improvement ideas that may spark new ideas for your practice.  Hear innovative ideas that practices are implementing to work smarter not harder to meet the demands of the new healthcare environment.   

Practice Disrupt

Gregory Austin and Dr. Chad Briscoe unzip, unlock, and uncover, the Stories Behind Medical Progress by sharing the latest and greatest advances in biopharmaceuticals and medical technologies in a fun, entertaining, and enlightening interview format. We bring on innovative leaders across the life sciences. The format is like a conversation you might overhear at the bar or at dinner after a day of great life science talks at a conference, engaging and accessible.

BioTalk Unzipped

Integrative doctor. Former ICU doctor &amp; surgeon. Unapologetically challenging the status quo in medicine, politics and current events. Founder of The James C...

Integrative doctor. Former ICU doctor & surgeon. Unapologetically challenging the status quo in medicine, politics and current events. Founder of The James C...

The Dr. Mollie James Show

Bienvenidos a Innóvate con Medical, un espacio informativo sobre los temas más actuales y de mayor interés en el área médica y bienestar integral, pensando siempre el el futuro de tu salud. <hr /> Hosted on Acast. See <a target="_blank" href="https://acast.com/privacy">acast.com/privacy</a> for more information.

Bienvenidos a Innóvate con Medical, un espacio informativo sobre los temas más actuales y de mayor interés en el área médica y bienestar integral, pensando siempre el el futuro de tu salud. Hosted on Acast. See acast.com/privacy for more information.

Bienvenidos a Innóvate con Medical, un espacio informativo sobre los temas más actuales y de mayor interés en el área médica y bienestar integral, pensando siempre el el futuro de tu salud. Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for more information.

Innóvate con Medical

«Lederpraten i Vestre Viken» er en podkast fra Vestre Viken helseforetak, der vi snakker med våre ledere om ledelse.<hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

«Lederpraten i Vestre Viken» er en podkast fra Vestre Viken helseforetak, der vi snakker med våre ledere om ledelse. Hosted on Acast. See acast.com/privacy for more information.

«Lederpraten i Vestre Viken» er en podkast fra Vestre Viken helseforetak, der vi snakker med våre ledere om ledelse. Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for more information.

Lederpraten i Vestre Viken

Enfermedades Raras

Through engaging conversations with industry experts, we aim to elevate awareness, advocate for advancements, and emphasize the crucial link between the healthcare supply chain and the well-being of individuals worldwide.

SCAN Health CAN

Hi, ich freue mich, dass du hierher gefunden hast! Wie schön, dass du da bist. Full Circle ist ein offener Ort an dem wir uns über ganzheitliche Gesundheit und die Body Mind Soul Connection austauschen, um Wissen zu teilen und Inspirationen mitzugeben. Denn nur wenn wir den Menschen als eine Einheit aus Körper, Geist und Seele sehen, können wir gesund und glücklich werden. Bei Full Circle werde ich über meine eigene Reise berichten und über meine Erfahrungen, aber auch Expert:Innen und Gäst:Innen einladen, die Themen und Visionen mitbringen, die mich beschäftigen oder interessieren. Wenn du dich für Holistic Health interessierst oder neugierig geworden bist, dann bist du hier genau richtig.&nbsp; Much love, mel&nbsp;

Hi, ich freue mich, dass du hierher gefunden hast! Wie schön, dass du da bist. Full Circle ist ein offener Ort an dem wir uns über ganzheitliche Gesundheit und die Body Mind Soul Connection austauschen, um Wissen zu teilen und Inspirationen mitzugeben. Denn nur wenn wir den Menschen als eine Einheit aus Körper, Geist und Seele sehen, können wir gesund und glücklich werden. Bei Full Circle werde ich über meine eigene Reise berichten und über meine Erfahrungen, aber auch Expert:Innen und Gäst:Innen einladen, die Themen und Visionen mitbringen, die mich beschäftigen oder interessieren. Wenn du dich für Holistic Health interessierst oder neugierig geworden bist, dann bist du hier genau richtig.  Much love, mel 

Full Circle - Body, Mind & Soul

Welcome to The Thrive Home — a space where stories of growth, wellness, and connection come to life. Hosted by members of the Department of Pediatrics at the Alberta Children's Hospital, this podcast explores what it means to thrive at work and at home. Through authentic conversations with leaders, residents, and team members, we uncover the journeys, lessons, and experiences that shape pediatric healthcare. Whether you’re part of our department, a healthcare professional, or simply curious about balance in high-pressure roles, The Thrive Home invites you to listen, reflect, and be inspired.

The Thrive Home

Cordell Wherler, jurist and outgoing Senator discusses hot topics of conservative and Libertarian politics and justice

THE jUDGEMENt With Cordell Wheeler

Join primary care physicians Michael Wilkes MD from UC Davis and Mark Ebell MD, MS from Michigan State University as they discuss a new practice changing study every week. Studies are selected for their ability to change our practice as primary care physicians for the better: POEMs = Patient Oriented Evidence that Matters.

Primary Care POEM of the Week with Drs. Mark Ebell and Mike Wilkes

Making the most natural and beautiful hair transplants. Having been in the cosmetic surgery industry since 1989, Dr Wayne has treated over 60000 patients with surgical and non surgical cosmetic treatments. He has been in the Hair Restoration industry since 2015, and has performed over 2400 hair transplant procedures. He is a member of FUEE, and WFI, FUE societies based in Europe. In addition to being an Associate Member of ISHRS. Dr Young uses the latest techniques and technologies to produce the most natural and safe hair restoration procedures for both male and female patients. He also restores eyebrow and beards and performs corrective hair restoration procedures.He also performs Total Unshaven Hair Transplants, one of the few clinics in the world to do this procedure technique. Each patient can expect an excellent bespoke procedure. That is both natural and appropriate for their face. The long term planning of your hair restoration journey is also very important to understand and Dr Young will thoroughly and completely explain this and the concept of Sustainable Hair Restoration. Dr Wayne does all consulting and reviews, to ensure the best results. Connect with us: Website- https://younghair.com.au/ email: info@younghair.com.au Instagram: https://www.instagram.com/younghairrestoration Youtube: https://www.youtube.com/channel/UCys2I6bpheI7J9F4mR1Z9zw Phone: (02) 8591 0215 Suite 109&nbsp; 19A Boundary Street Darlinghurst&nbsp; NSW.

Making the most natural and beautiful hair transplants. Having been in the cosmetic surgery industry since 1989, Dr Wayne has treated over 60000 patients with surgical and non surgical cosmetic treatments. He has been in the Hair Restoration industry since 2015, and has performed over 2400 hair transplant procedures. He is a member of FUEE, and WFI, FUE societies based in Europe. In addition to being an Associate Member of ISHRS. Dr Young uses the latest techniques and technologies to produce the most natural and safe hair restoration procedures for both male and female patients. He also restores eyebrow and beards and performs corrective hair restoration procedures. He also performs Total Unshaven Hair Transplants, one of the few clinics in the world to do this procedure technique. Each patient can expect an excellent bespoke procedure. That is both natural and appropriate for their face. The long term planning of your hair restoration journey is also very important to understand and Dr Young will thoroughly and completely explain this and the concept of Sustainable Hair Restoration. Dr Wayne does all consulting and reviews, to ensure the best results. Connect with us: Website- https://younghair.com.au/ email: info@younghair.com.au Instagram: https://www.instagram.com/younghairrestoration Youtube: https://www.youtube.com/channel/UCys2I6bpheI7J9F4mR1Z9zw Phone: (02) 8591 0215 Suite 109  19A Boundary Street Darlinghurst  NSW.

Young Hair Restoration

La Mutualité Française s'implique pour développer l'offre et l'accessibilité des soins partout sur tout le territoire, avec notamment l'ouverture d'un centre de Santé à Tarbes, une zone sous-dotée, à la demande de l'ARS en décembre 2023. Nous vous emmenons en immersion aux pieds des Pyrénées à la rencontre des médecins, personnels paramédicaux et patients. Lutte contre les déserts médicaux, offre de soin de qualité et implantation dans l'écosystème de soin local au programme ! Au cœur du soin est un podcast réalisé par What’s Up Doc en partenariat avec la Mutualité Française.

La Mutualité Française s'implique pour développer l'offre et l'accessibilité des soins partout sur tout le territoire, avec notamment l'ouverture d'un centre de Santé à Tarbes, une zone sous-dotée, à la demande de l'ARS en décembre 2023. Nous vous emmenons en immersion aux pieds des Pyrénées à la rencontre des médecins, personnels paramédicaux et patients. Lutte contre les déserts médicaux, offre de soin de qualité et implantation dans l'écosystème de soin local au programme ! Au cœur du soin est un podcast réalisé par What’s Up Doc en partenariat avec la Mutualité Française.

La Mutualité Française s'implique pour développer l'offre et l'accessibilité des soins partout sur tout le territoire, avec notamment l'ouverture d'un&nbsp;centre de Santé à Tarbes, une zone sous-dotée, à la demande de l'ARS en décembre 2023. Nous vous emmenons en immersion aux pieds des Pyrénées à la rencontre des médecins, personnels paramédicaux et patients. Lutte contre les déserts médicaux, offre de soin de qualité et implantation dans l'écosystème de soin local au programme !&nbsp;Au cœur du soin est un podcast réalisé par What’s Up Doc en partenariat avec la Mutualité Française.

Au coeur du soin

The ARF Pharma Council has launched an on-demand series of webcasts and podcasts on “Trends in the Patient Journey: What to Expect in the Next 3-5 Years.” In this series, the Council explores the future patient journey through the lens of experts and companies working on the cutting edge of current trends in health care marketing and delivery

Pharma Council - FutureHealth

La voix des libéraux est le podcast qui relaie vos questions, vos préoccupations et vos doléances concernant votre activité de médecin libéral. 

Vous êtes médecin ? Chaque mois, un invité répondra à vos questions sur un sujet qui fait l'actualité de votre profession. A chaque épisode, un nouveau thème. Posez vos questions sur notre boîte vocale ici : https://voxm.io/p/WN6r0

Un podcast produit par l'URPS médecins libéraux Ile-de-France, avec Logarythm.
Hébergé par Ausha. Visitez ausha.co/fr/politique-de-confidentialite pour plus d'informations.

La voix des libéraux est le podcast qui relaie vos questions, vos préoccupations et vos doléances concernant votre activité de médecin libéral. Vous êtes médecin ? Chaque mois, un invité répondra à vos questions sur un sujet qui fait l'actualité de votre profession. A chaque épisode, un nouveau thème. Posez vos questions sur notre boîte vocale ici : https://voxm.io/p/WN6r0 Un podcast produit par l'URPS médecins libéraux Ile-de-France, avec Logarythm. Hébergé par Ausha. Visitez ausha.co/fr/politique-de-confidentialite pour plus d'informations.

La voix des libéraux est le podcast qui relaie vos questions, vos préoccupations et vos doléances concernant votre activité de médecin libéral.&nbsp;

Vous êtes médecin ? Chaque mois, un invité répondra à vos questions sur un sujet qui fait l'actualité de votre profession. A chaque épisode, un nouveau thème. Posez vos questions sur notre boîte vocale ici : https://voxm.io/p/WN6r0

Un podcast produit par l'URPS médecins libéraux Ile-de-France, avec Logarythm.
Hébergé par Ausha. Visitez ausha.co/fr/politique-de-confidentialite pour plus d'informations.

La voix des libéraux

The Elite Athlete Podcast is your go-to resource for cutting-edge strategies and expert guidance, all geared towards helping high-level athletes achieve their peak performance. Hosted by Dr. Nicole Tatro—a former college athlete, coach, and health professional—each episode dives into the essential elements of athletic success, from advanced training techniques and nutrition strategies to mastering the mental game and adopting next-level health strategies.

This podcast goes beyond the basics, highlighting the importance of bloodwork analysis and personalized health optimization. Dr. Nicole reveals how understanding your body's unique needs can unlock greater performance, enhance recovery, and boost sustained energy levels. Whether you’re an aspiring athlete, a dedicated parent, or a coach aiming to elevate your team's performance, this podcast offers practical tools and proven methods vital for those serious about dominating their sport.

Listen in for discussions that empower you to train smarter, recover quicker, and perform at your absolute best—every time. Featuring elite athletes, seasoned coaches, and industry experts, each episode provides valuable insights to help you advance in your athletic journey.

Join Dr. Nicole and a community of high-level performers committed to excellence. Visit www.the-eliteathlete.com to learn more about leveraging bloodwork and personalized strategies to enhance your health and performance.

The Elite Athlete Podcast is your go-to resource for cutting-edge strategies and expert guidance, all geared towards helping high-level athletes achieve their peak performance. Hosted by Dr. Nicole Tatro—a former college athlete, coach, and health professional—each episode dives into the essential elements of athletic success, from advanced training techniques and nutrition strategies to mastering the mental game and adopting next-level health strategies. This podcast goes beyond the basics, highlighting the importance of bloodwork analysis and personalized health optimization. Dr. Nicole reveals how understanding your body's unique needs can unlock greater performance, enhance recovery, and boost sustained energy levels. Whether you’re an aspiring athlete, a dedicated parent, or a coach aiming to elevate your team's performance, this podcast offers practical tools and proven methods vital for those serious about dominating their sport. Listen in for discussions that empower you to train smarter, recover quicker, and perform at your absolute best—every time. Featuring elite athletes, seasoned coaches, and industry experts, each episode provides valuable insights to help you advance in your athletic journey. Join Dr. Nicole and a community of high-level performers committed to excellence. Visit www.the-eliteathlete.com to learn more about leveraging bloodwork and personalized strategies to enhance your health and performance.

The Elite Athlete Podcast

ClinPharmPod is our channel from <a href="https://ascpt.onlinelibrary.wiley.com/journal/15326535" target="_blank" rel="noopener noreferrer">Clinical Pharmacology & Therapeutics</a>. Join us as we delve into the advances in the nature, action, efficacy, and evaluation of therapeutics in this cross-disciplinary field of experimental and clinical medicine featuring highlighted content from the one of the top journals in clinical pharmacology and therapeutics.

ClinPharmPod is our channel from Clinical Pharmacology & Therapeutics. Join us as we delve into the advances in the nature, action, efficacy, and evaluation of therapeutics in this cross-disciplinary field of experimental and clinical medicine featuring highlighted content from the one of the top journals in clinical pharmacology and therapeutics.

ClinPharmPod is our channel from <a href="https://ascpt.onlinelibrary.wiley.com/journal/15326535" rel="noopener noreferrer">Clinical Pharmacology &amp; Therapeutics</a>. Join us as we delve into the advances in the nature, action, efficacy, and evaluation of therapeutics in this cross-disciplinary field of experimental and clinical medicine featuring highlighted content from the one of the top journals in clinical pharmacology and therapeutics.

ClinPharmPod

Medical Rewrites is the podcast that rewrites movie scenes with evidence-based medicine. Come for the clinical pearls, stay for the tangents.This podcast analyzes movie scenes with medical plot points that fall short of best practices then rewrite the scene or dialogue.Schedule: Q14 days on WednesdayGuest experts: PRN

Medical Rewrites is the podcast that rewrites movie scenes with evidence-based medicine. Come for the clinical pearls, stay for the tangents. This podcast analyzes movie scenes with medical plot points that fall short of best practices then rewrite the scene or dialogue. Schedule: Q14 days on Wednesday Guest experts: PRN

Medical Rewrites

This is my very interesting podcast<hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

This is my very interesting podcast Hosted on Acast. See acast.com/privacy for more information.

This is my very interesting podcast Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for more information.

Ana Morales's podcast

<a href="https://curatedwellness.com/" rel="noopener noreferrer" target="_blank">Curated Wellness</a> empowers and inspires you to live your best and healthiest life by providing sustainable and practical solutions to eliminate the guesswork around nutrition and supplements.

Curated Wellness empowers and inspires you to live your best and healthiest life by providing sustainable and practical solutions to eliminate the guesswork around nutrition and supplements.

<a href="https://curatedwellness.com/" rel="noopener noreferrer">Curated Wellness</a> empowers and inspires you to live your best and healthiest life by providing sustainable and practical solutions to eliminate the guesswork around nutrition and supplements.

Curated Wellness

Discover the benefits of using ReliableRxPharmacy for all your medication needs. Learn about its commitment to quality, affordability, and excellent customer service.

ReliableRxPharmacy: Your Trusted Online Pharmacy

Родители, без паники! Отвечаем на все вопросы о здоровье и воспитании ребенкаСайт Купрума: <a href="https://cuprum.media">https://cuprum.media</a> Подписывайтесь на наши соцсети: <ul><li>ВКонтакте: https://vk.com/cuprum.media</li><li>Телеграм: https://t.me/tolkosprosit</li><li>Дзен: https://dzen.ru/cuprum</li><li>Бот в Телеграм: https://t.me/cuprum_media_bot?start=link_KNe4c7lDAF</li></ul> Написать нам: cuprummediamail@yandex.ru

Родители, без паники! Отвечаем на все вопросы о здоровье и воспитании ребенка Сайт Купрума: https://cuprum.media Подписывайтесь на наши соцсети:ВКонтакте: https://vk.com/cuprum.mediaТелеграм: https://t.me/tolkosprositДзен: https://dzen.ru/cuprumБот в Телеграм: https://t.me/cuprum_media_bot?start=link_KNe4c7lDAFНаписать нам: cuprummediamail@yandex.ru

Родители, без паники! Отвечаем на все вопросы о здоровье и воспитании ребенкаСайт Купрума:&nbsp;<a href="https://cuprum.media" rel="noopener noreferrer">https://cuprum.media</a> Подписывайтесь на наши соцсети: <ul><li>ВКонтакте: https://vk.com/cuprum.media</li><li>Телеграм: https://t.me/tolkosprosit</li><li>Дзен: https://dzen.ru/cuprum</li><li>Бот в Телеграм: https://t.me/cuprum_media_bot?start=link_KNe4c7lDAF</li></ul> Написать нам: cuprummediamail@yandex.ru

По чайной ложке

El podcast "Hablemos de genetica" es una serie de episodios que explora la ciencia de la genética y su relación con la salud humana. Cada episodio aborda un tema específico, como la herencia genética, la maternidad, el cancer y las enfermedades genéticas. Lo presentamos en un lenguaje accesible para el público general. A través de información de expertos en el campo, el podcast ofrece datos actualizada sobre los avances en la investigación genética y cómo se pueden aplicar estos conocimientos para mejorar la salud y el bienestar de las personas.

El podcast "Hablemos de genetica" es una serie de episodios que explora la ciencia de la genética y su relación con la salud humana. Cada episodio aborda un tema específico, como la herencia genética, la maternidad, el cancer y las enfermedades genéticas. Lo presentamos en un lenguaje accesible para el público general. A través de información de expertos en el campo, el podcast ofrece datos actualizada sobre los avances en la investigación genética y cómo se pueden aplicar estos conocimientos para mejorar la salud y el bienestar de las personas.

Nanolab, Hablemos de Genética

Join us as we delve into the scientific intricacies and therapeutic potential of Suhagra 50, exploring its development, mechanism of action, and clinical implications. This in-depth analysis offers a glimpse into the meticulous research and ethical considerations behind its use in healthcare.

Medicine Podcasts / Page 244

Pharmacy Life Radio

Thought For Food Podcast

Dermatologic Oncology Update

Ganzheitliche Kindergesundheit

Maxillofacial Surgery

Malaria Vaccine

HEALS POD

Voices of Women Physicians

Just Medicine

Practice Disrupt

BioTalk Unzipped

The Dr. Mollie James Show

Innóvate con Medical

Lederpraten i Vestre Viken

Enfermedades Raras

SCAN Health CAN

Full Circle - Body, Mind & Soul

The Thrive Home

THE jUDGEMENt With Cordell Wheeler

Primary Care POEM of the Week with Drs. Mark Ebell and Mike Wilkes

Young Hair Restoration

Au coeur du soin

Pharma Council - FutureHealth

La voix des libéraux

The Elite Athlete Podcast

ClinPharmPod

Medical Rewrites

Ana Morales's podcast

Curated Wellness

ReliableRxPharmacy: Your Trusted Online Pharmacy

По чайной ложке

Nanolab, Hablemos de Genética

An Insight into Suhagra 50

2iC-Care: Caring for the Future

A Deep Dive into NorthWest Pharmacy

لیدوپاد / LIDOPOD

Eggcited explore new ways to grow your family

pulse and pace

Dr Kirren - Bridging Medical Paradigms

Esomeprazol VIR 20mg C Gastrorresistentes EFG

AmbuChat: An EMS podcast.

Chill Pill

Science Bytes

The Health Detective

LSNH - Anatomie

Al Natural Bites

Living Healthy Together

Introducing Lipoma Wand: A Modern Solution

Sick Society

微信公众号粉丝增长，自动化平台系统让你轻松获取活跃用户